Cell Therapy News Volume 23.18 | May 30 2022

    0
    169







    2022-05-30 | CTN 23.18


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.18 – 30 May, 2022
    TOP STORY

    Mobilization-Based Chemotherapy-Free Engraftment of Gene-Edited Human Hematopoietic Stem Cells

    The authors showed that mobilizers created an opportunity for seamless engraftment of exogenous cells, which effectively outcompeted those mobilized, to repopulate the depleted bone marrow.
    [Cell]

    Full ArticleGraphical Abstract
    How have LSCs changed our understanding of myeloid malignancies? Webinar by Dr. Christopher Park, NYU
    PUBLICATIONSRanked by the impact factor of the journal

    Target Receptor Identification and Subsequent Treatment of Resected Brain Tumors with Encapsulated and Engineered Allogeneic Stem Cells

    Scientists showed the detection of cell surface death receptor target on CD146-enriched circulating tumor cells captured from the blood of mice bearing glioblastoma (GBM) and patients diagnosed with GBM.
    [Nature Communications]

    Full ArticlePress Release

    Phenotypic Composition of Commercial Anti-CD19 CAR-T Cells Affects In Vivo Expansion and Disease Response in Large B Cell Lymphoma Patients

    Residual cells obtained after washing 61 anti-CD19 CAR-T product bags were analyzed to identify tisagenlecleucel/Tisa-cel and axicabtagene ciloleucel/Axi-cel phenotypic features associated with post-infusion CAR-T cell in vivo expansion and with response and survival.
    [Clinical Cancer Research]

    Abstract

    The CAR-HEMATOTOX Risk-Stratifies Patients for Severe Infections and Disease Progression after CD19 CAR-T in R/R LBCL

    In this multicenter retrospective analysis, researchers characterized early infection events and clinical outcomes in 248 patients receiving standard-of-care CD19 CAR-T for relapsed/refractory large B cell lymphoma.
    [Journal For Immunotherapy of Cancer]

    Full Article

    Oral Delivery of Stem-Cell-Loaded Hydrogel Microcapsules Restores Gut Inflammation and Microbiota

    The oral delivery of stem-cell-loaded hydrogel microcapsules enhanced mesenchymal stem cell survival and retention in the hostile stomach environment due to the intermediate oil layer and low value of the overall stiffness.
    [Journal of Controlled Release]

    AbstractGraphical Abstract

    Impact of PET-CT Status on Progression-Free Survival for Relapsed Follicular Lymphoma Patients Undergoing Autologous Stem Cell Transplant

    Investigators described survival outcomes according to autologous stem cell transplantation PET status according to Lugano criteria in 172 relapsed or refractory (R/R) follicular lymphoma patients within a national, multicentre, retrospective BSBMTCT registry study.
    [Haematologica]

    Abstract

    Durable Discontinuation of Systemic Therapy in Patients Affected by Chronic Graft-versus-Host Disease

    Scientists evaluated the factors associated with durable systemic therapy (ST) discontinuation, defined as cessation of all ST for ≥12 months, using data from two prospectively followed cohorts from the chronic graft-versus-host disease Consortium.
    [Haematologica]

    Abstract

    Standard Toxicity Study of Clinical-Grade Allogeneic Human Bone Marrow-Derived Clonal Mesenchymal Stromal Cells

    The authors determined the probable toxicity effects of local and systemic injections of cryopreserved human bone marrow-derived clonal mesenchymal stem cell during subacute and subchronic periods of time.
    [Stem Cell Research & Therapy]

    Full Article

    Periodontal Tissue Regeneration by Transplantation of Autologous Adipose Tissue-Derived Multi-Lineage Progenitor Cells

    Scientists conducted an open-label, single-arm exploratory Phase I clinical study in which 12 periodontitis patients were transplanted with autologous adipose tissue-derived multi-lineage progenitor cells isolated from subcutaneous adipose tissue.
    [Scientific Reports]

    Full Article

    CD38: A Target in Relapsed/Refractory Acute Lymphoblastic Leukemia—Limitations in Treatment and Diagnostics

    Researchers treated five patients suffering from relapsed acute lymphoblastic leukemia (ALL) with daratumumab. Four patients had T ALL, three of whom achieved complete remission after treatment and underwent stem cell transplant.
    [Pediatric Blood & Cancer]

    Abstract
    ON712CXN-Cancer-728-x-90-1
    REVIEWS

    Emerging Tissue Engineering Strategies for the Corneal Regeneration

    The authors discuss the application and limitation of the recently-used advanced approaches for regeneration of cornea. [Journal of Tissue Engineering and Regenerative Medicine]
    [nan]

    Abstract
    INDUSTRY AND POLICY NEWS

    Research Animals Mistreated by Leading Supplier, Animal Welfare Group Alleges

    The contract research organization Inotiv is neglecting animals at a research facility in Indiana that conducts toxicity testing of experimental drugs, the Humane Society of the United States alleged.
    [ScienceInsider]

    Press Release

    Neurona Therapeutics Awarded $8 Million by California Institute for Regenerative Medicine (CIRM) to Support Phase I/II Clinical Trial of NRTX-1001 for Chronic Focal Epilepsy

    Neurona Therapeutics announced that it has been awarded a $7,999,999 grant by the California Institute for Regenerative Medicine to support a dose-escalation Phase I/II clinical trial of NRTX-1001, an inhibitory cell therapy that is being evaluated for safety and efficacy in people with drug-resistant mesial temporal lobe epilepsy.
    [Neurona Therapeutics]

    Press Release
    FEATURED EVENT

    Neurobiology of Brain Disorders

    August 7 – 12, 2022
    Castelldefels, Spain

    > See All Events

    JOB OPPORTUNITIES

    Post-Doctoral Fellow – Translational Immunology in Cell Therapies

    Columbia University – New York, New York, United States

    Research Analyst – Biofabrication

    Utrecht University – Utrecht, Netherlands

    Specialist – Cell Therapy Quality Assurance

    Bristol Myers Squibb – Devens, Massachusetts, United States

    Postdoctoral Fellow – Immuno-Oncology/Vascular Biology Research

    Johns Hopkins University School of Medicine – St. Petersburg, Florida, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter